Synergetics Biomedical 2025 Q4 Financial Report
Synergetics Biomedical Investment Holdings Co., Ltd. announced its Q4 2025 financial results, reporting a basic EPS of 1.00 NTD, operating revenue of 4.398 billion NTD, and a net income after tax of 226 million NTD.
📋 Article Processing Timeline
- 📰 Published: December 1, 2025 at 09:00
- 🔍 Collected: April 7, 2026 at 08:00 (3047h 0m after Published)
- 🤖 AI Analyzed: April 8, 2026 at 00:20 (16h 20m after Collected)
Company Code: 4164 Company Name: Synergetics Biomedical Investment Holdings Co., Ltd. Industry: Biotechnology and Medical Industry Year/Quarter: 2025 Q4 Basic Earnings Per Share (EPS): 1.00 NTD Operating Revenue: 4.398 billion NTD Net Income After Tax: 226 million NTD